Glucagon/GLP-1 receptor co-agonists
First Claim
Patent Images
1. A peptide comprising the amino acid sequence of SEQ ID NO:
- 17, or a pharmaceutically acceptable salt thereof.
1 Assignment
0 Petitions
Accused Products
Abstract
Provided herein are peptides and variant peptides that exhibit enhanced activity at the GLP-1 receptor, as compared to native glucagon.
79 Citations
28 Claims
-
1. A peptide comprising the amino acid sequence of SEQ ID NO:
- 17, or a pharmaceutically acceptable salt thereof.
- View Dependent Claims (2, 3, 4, 5, 6, 7)
- 8. A peptide comprising the amino acid sequence of SEQ ID NO:
-
15. A peptide consisting of the amino acid sequence of SEQ ID NO:
- 17 or a pharmaceutically acceptable salt thereof.
- View Dependent Claims (16, 17, 18, 19, 20, 21)
- 22. A peptide consisting of the amino acid sequence of SEQ ID NO:
Specification